LABTRACE.ORG BETA LIVE
236 source polls this hour 76 676 articles collected last article 4m ago 1443 events on 2+ sources 0 embeddings/h feed queue 0 lag 290.9s
← health
LT-037916 / first seen 2026-11-04 16:54 / last activity 2h ago

Phase I/II Study of Bavdegalutamide, a Proteolysis-Targeting Chimera Androgen Receptor Degrader, in Metastatic Castration-Resistant Prostate Cancer

measurement

heat
45 / 100 (raw 1.2)
velocity
0.0 independent sources per hour
solidity
80 / 100
sources
1 total, 1 independent
domain span
1 domain covered it

primary source

title
Phase I/II Study of Bavdegalutamide, a Proteolysis-Targeting Chimera Androgen Receptor Degrader, in Metastatic Castration-Resistant Prostate Cancer
venue
status
peer-reviewed
doi
10.1200/jco-25-02995
published
2026-10-09

media coverage / 1 outlets